Breast Cancer Clinical Trial
— PITCAOfficial title:
Pilot Study Evaluating a Perioperative E-follow-up Protocol in Patients With Ambulatory Surgery for Breast Cancer
Verified date | August 2018 |
Source | Institut Claudius Regaud |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a monocentric, prospective cohort study evaluating the feasibility of a perioperative
e-follow-up protocol in patients with ambulatory surgery for breast cancer.
This protocol will be based on:
- A coordinated ambulatory follow-up performed by a dedicated nurse
- An electronic follow-up tool used in pre- and post-surgery
Patients will be followed 8 days before the surgery until 30 days after the surgery of breast
cancer.
Status | Completed |
Enrollment | 40 |
Est. completion date | June 29, 2018 |
Est. primary completion date | June 29, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Patient eligible for an ambulatory surgery of breast cancer (partial mastectomy with or without lymph node sampling) 2. Ambulatory surgery planned 10 days or more after inclusion date 3. Age > or = 18 years old 4. Affiliated to the french social security system 5. Patient must provide written informed consent prior to any study-specific procedure or assessment Exclusion Criteria: 1. Surgery other than breast cancer surgery in ambulatory (benign breast surgery, other surgical specialities) 2. Patient who cannot connect to the electronic tool at home (no computer, no tablet computer or no internet connection) 3. Pregnant or breastfeeding women 4. Any psychological, familial, geographic or social situation, according to the judgment of investigator, potentially preventing the provision of informed consent or compliance to study procedure 5. Patient protected by law |
Country | Name | City | State |
---|---|---|---|
France | Institut Claudius Regaud IUCT-ONCOPOLE | Toulouse |
Lead Sponsor | Collaborator |
---|---|
Institut Claudius Regaud |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of patients without failure to the e-follow-up. A failure is defined by absence of connection to the electronic tool and the mismatch between the alert level and severity of complications. | 1.5 months by patient | ||
Secondary | Patient satisfaction to the e-follow-up. | Satisfaction will be evaluated by questionnaire. | 1.5 months by patient | |
Secondary | The rate of patients who discontinue the study 8 days before the surgery. | 1.5 months by patient | ||
Secondary | The number of unplanned visits into the Center after ambulatory surgery in the first 24 hours and during the first 30 days will be assessed for each patient. | 1.5 months by patient | ||
Secondary | Rate of patients with at least one unplanned visit. | 1.5 months by patient | ||
Secondary | The time spent by the dedicated nurse for the follow-up protocol management. | It will be defined as the sum of the time spent at different stages: initial training of patients, tracking of the connections to the tool, tracking of the alerts and telephone contacts. | 1.5 months by patient |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Recruiting |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |